Dow Jones

39,118.86

-0.12%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

QBIO

Q BioMed (CE) (QBIO)

Q BioMed Inc (CE)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:QBIO

Fecha	Hora	Fuente	Título	Símbolo	Compañía
16/06/2023	15:01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
26/05/2023	15:56	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:QBIO	Q BioMed Inc (CE)
01/03/2023	12:02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:QBIO	Q BioMed Inc (CE)
07/12/2022	14:01	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:QBIO	Q BioMed Inc (CE)
18/11/2022	16:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
15/07/2022	16:01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2022	15:36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
26/02/2021	11:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2021	05:01	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:QBIO	Q BioMed Inc (CE)
15/09/2020	07:53	InvestorsHub NewsWire	Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe	USOTC:QBIO	Q BioMed Inc (CE)
26/08/2020	06:30	InvestorsHub NewsWire	Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program	USOTC:QBIO	Q BioMed Inc (CE)
11/08/2020	07:05	InvestorsHub NewsWire	Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain	USOTC:QBIO	Q BioMed Inc (CE)
11/06/2020	11:13	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:QBIO	Q BioMed Inc (CE)
21/05/2020	12:51	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:QBIO	Q BioMed Inc (CE)
11/05/2020	05:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:QBIO	Q BioMed Inc (CE)
19/03/2020	15:26	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:QBIO	Q BioMed Inc (CE)
16/12/2019	14:08	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:QBIO	Q BioMed Inc (CE)
06/09/2019	13:16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:QBIO	Q BioMed Inc (CE)
19/03/2019	10:20	InvestorsHub NewsWire	GDET CEO Interviewed By Goldman Small Cap Research On New Cannabis Business	USOTC:QBIO	Q BioMed Inc (CE)
13/12/2018	14:25	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:QBIO	Q BioMed Inc (CE)
06/12/2018	13:51	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:QBIO	Q BioMed Inc (CE)
19/10/2018	09:47	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:QBIO	Q BioMed Inc (CE)
08/06/2018	10:54	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	USOTC:QBIO	Q BioMed Inc (CE)
26/02/2018	14:23	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:QBIO	Q BioMed Inc (CE)
04/10/2017	16:08	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:QBIO	Q BioMed Inc (CE)
10/03/2017	15:10	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:QBIO	Q BioMed Inc (CE)
27/07/2016	08:00	InvestorsHub NewsWire	Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements	USOTC:QBIO	Q BioMed Inc (CE)
30/10/2015	07:21	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	USOTC:QBIO	Q BioMed Inc (CE)